HCA Healthcare Adopts 2026 Executive Performance Incentive Program
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from HCA Healthcare ( (HCA) ) is now available.
On February 24, 2026, HCA Healthcare’s board compensation committee approved a 2026 Executive Officer Performance Excellence Program that ties senior leaders’ cash incentive awards primarily to EBITDA performance, with 80% of payouts linked to profit targets and 20% tied to quality metrics in areas such as infections, sepsis, complications, mortality, and patient experience. The plan sets target bonus opportunities ranging from 100% to 175% of base salary for named executives, uses threshold-to-maximum payout scales up to 200%, conditions quality payouts on achieving at least 90% of EBITDA targets, and includes broad committee discretion, adjustment, and clawback provisions, while separately, director Robert J. Dennis notified the company on February 20, 2026, that he will retire from the board at the April 23, 2026 annual shareholders’ meeting.
The most recent analyst rating on (HCA) stock is a Buy with a $585.00 price target. To see the full list of analyst forecasts on HCA Healthcare stock, see the HCA Stock Forecast page.
Spark’s Take on HCA Stock
According to Spark, TipRanks’ AI Analyst, HCA is a Outperform.
The score is driven by strong operating performance and cash generation plus a clearly positive price trend. The biggest offset is elevated balance-sheet risk (high debt and negative equity), and guidance includes meaningful policy/reimbursement headwinds that increase execution risk despite management’s mitigation plans and enhanced shareholder returns.
To see Spark’s full report on HCA stock, click here.
More about HCA Healthcare
HCA Healthcare, Inc. is a large U.S. health care services company that operates hospitals and related facilities, generating revenue primarily from acute care and clinical services. The company competes in the hospital and health systems sector, where operational efficiency, quality of care, and clinical outcomes are key drivers of financial performance and executive incentives.
Average Trading Volume: 1,166,356
Technical Sentiment Signal: Buy
Current Market Cap: $117.7B
Find detailed analytics on HCA stock on TipRanks’ Stock Analysis page.
